BioCentury | Oct 28, 2020
Finance

Oct. 27 Financial Quick Takes: Apellis-Sobi deal for C3 inhibitor; plus Primmune, Prokarium, Novartis-RegenxBio, Turning Point, Psyomics, Journey Colab

...raised £1.5 million in a round led by Parkwalk and joined by Jonathan Milner, Martlet and Cambridge Enterprise...
BioCentury | Jul 17, 2020
Finance

July 16 Quick Takes: Biotech stocks fare worse than others in STAR tumble; plus BioAtla, Exalys, Virometix, Biose, Spirea

...not disclosed. The newco has previously received investment from Innovate UK, IP Group plc and Cambridge Enterprise BioCentury...
BioCentury | Jul 30, 2019
Financial News

June 30 Financial Quick Takes: $40M series B for Hinova; plus TriArm and PredictImmune raise rounds

...B round, with new investors BGF and Cambridge Innovation Capital joining existing investors Parkwalk and Cambridge Enterprise...
BioCentury | Apr 30, 2019
Financial News

April 30 Financial Quick Takes: Mustang, Tot Biopharm, Axcella and more

...with £3.4 million ($4.4 million) in seed funding from Cambridge Innovation Capital, RT Capital and Cambridge Enterprise...
BioCentury | Feb 22, 2019
Emerging Company Profile

Gyroscope complements dry AMD

...Southampton Corporate partners: None Number of employees: 35 Funds raised: $34.13 million Investors: Syncona Ltd, Cambridge Enterprise...
BioCentury | Dec 21, 2018
Financial News

Medicxi leads Morphogen-IX’s £18.4M series B

...in a series B round led by Medicxi with participation from Cambridge Innovation Capital and Cambridge Enterprise...
BioCentury | Dec 18, 2018
Financial News

Medicxi leads Morphogen-IX’s £18.4M series B

...in a series B round led by Medicxi with participation from Cambridge Innovation Capital and Cambridge Enterprise...
BioCentury | Aug 10, 2018
Company News

Astellas acquires ophthalmic company Quethera

...neuroscience and ophthalmology at University of Cambridge. Quethera received undisclosed seed funding in 2015 from Cambridge Enterprise...
BioCentury | Apr 17, 2018
Company News

Management tracks: Frequency, AACR, NextCode

...sciences research. Holbrook was director of life science seed funds at the University of Cambridge's Cambridge Enterprise...
BioCentury | Oct 20, 2017
Finance

Stars align for rare AMD

...in May 2016, Gyroscope has raised an undisclosed seed financing from Syncona Ltd. (LSE:SYNC) and Cambridge Enterprise. Stephen...
Items per page:
1 - 10 of 42
BioCentury | Oct 28, 2020
Finance

Oct. 27 Financial Quick Takes: Apellis-Sobi deal for C3 inhibitor; plus Primmune, Prokarium, Novartis-RegenxBio, Turning Point, Psyomics, Journey Colab

...raised £1.5 million in a round led by Parkwalk and joined by Jonathan Milner, Martlet and Cambridge Enterprise...
BioCentury | Jul 17, 2020
Finance

July 16 Quick Takes: Biotech stocks fare worse than others in STAR tumble; plus BioAtla, Exalys, Virometix, Biose, Spirea

...not disclosed. The newco has previously received investment from Innovate UK, IP Group plc and Cambridge Enterprise BioCentury...
BioCentury | Jul 30, 2019
Financial News

June 30 Financial Quick Takes: $40M series B for Hinova; plus TriArm and PredictImmune raise rounds

...B round, with new investors BGF and Cambridge Innovation Capital joining existing investors Parkwalk and Cambridge Enterprise...
BioCentury | Apr 30, 2019
Financial News

April 30 Financial Quick Takes: Mustang, Tot Biopharm, Axcella and more

...with £3.4 million ($4.4 million) in seed funding from Cambridge Innovation Capital, RT Capital and Cambridge Enterprise...
BioCentury | Feb 22, 2019
Emerging Company Profile

Gyroscope complements dry AMD

...Southampton Corporate partners: None Number of employees: 35 Funds raised: $34.13 million Investors: Syncona Ltd, Cambridge Enterprise...
BioCentury | Dec 21, 2018
Financial News

Medicxi leads Morphogen-IX’s £18.4M series B

...in a series B round led by Medicxi with participation from Cambridge Innovation Capital and Cambridge Enterprise...
BioCentury | Dec 18, 2018
Financial News

Medicxi leads Morphogen-IX’s £18.4M series B

...in a series B round led by Medicxi with participation from Cambridge Innovation Capital and Cambridge Enterprise...
BioCentury | Aug 10, 2018
Company News

Astellas acquires ophthalmic company Quethera

...neuroscience and ophthalmology at University of Cambridge. Quethera received undisclosed seed funding in 2015 from Cambridge Enterprise...
BioCentury | Apr 17, 2018
Company News

Management tracks: Frequency, AACR, NextCode

...sciences research. Holbrook was director of life science seed funds at the University of Cambridge's Cambridge Enterprise...
BioCentury | Oct 20, 2017
Finance

Stars align for rare AMD

...in May 2016, Gyroscope has raised an undisclosed seed financing from Syncona Ltd. (LSE:SYNC) and Cambridge Enterprise. Stephen...
Items per page:
1 - 10 of 42